Mirian Brink

1.5k total citations
30 papers, 1.1k citations indexed

About

Mirian Brink is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Mirian Brink has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 4 papers in Surgery. Recurrent topics in Mirian Brink's work include Lymphoma Diagnosis and Treatment (13 papers), Genetic factors in colorectal cancer (8 papers) and Colorectal Cancer Screening and Detection (6 papers). Mirian Brink is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Genetic factors in colorectal cancer (8 papers) and Colorectal Cancer Screening and Detection (6 papers). Mirian Brink collaborates with scholars based in Netherlands, Belgium and United States. Mirian Brink's co-authors include Piet A. van den Brandt, Matty P. Weijenberg, Adriaan P. de Bruı̈ne, Guido M.J.M. Roemen, R. Alexandra Goldbohm, Manon van Engeland, James G. Herman, Anton F.P.M. de Goeij, Stephen B. Baylin and Marjolein H.F.M. Lentjes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncogene.

In The Last Decade

Mirian Brink

28 papers receiving 1.0k citations

Peers

Mirian Brink

ONCOL

PFM

PRM

Jae‐Yong Kwak South Korea

Ajay Gogia India

Alexandra M. Harrington United States

Aliza Leiser United States

Eleanor V. Willett United Kingdom

Yeşim Eralp Türkiye

Samar Alhomoud Saudi Arabia

Jae‐Cheol Jo South Korea

Scott Winkel United States

E. Marcuello Spain

Jae‐Yong Kwak South Korea

Mirian Brink

398 ×0.8

ONCOL

233 ×0.5

468 ×1.1

PFM

125 ×0.6

103 ×0.8

PRM

Citations per year, relative to Mirian Brink Mirian Brink (= 1×) peers Jae‐Yong Kwak

Countries citing papers authored by Mirian Brink

Since Specialization

Citations

This map shows the geographic impact of Mirian Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirian Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirian Brink more than expected).

Fields of papers citing papers by Mirian Brink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirian Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirian Brink. The network helps show where Mirian Brink may publish in the future.

Co-authorship network of co-authors of Mirian Brink

This figure shows the co-authorship network connecting the top 25 collaborators of Mirian Brink. A scholar is included among the top collaborators of Mirian Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirian Brink. Mirian Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brink, Mirian, Marjolein van der Poel, Marie José Kersten, et al.. (2024). Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry. Blood Advances. 8(14). 3619–3628. 7 indexed citations

Brink, Mirian, Wouter J. Plattel, Joost S.P. Vermaat, et al.. (2024). Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands. SHILAP Revista de lepidopterología. 5(6). 1215–1222.

Brink, Mirian, Wouter J. Plattel, Marjolein van der Poel, et al.. (2023). Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands. Haematologica. 109(4). 1163–1170. 5 indexed citations

Brink, Mirian, Martine E.D. Chamuleau, Rolf E. Brouwer, et al.. (2023). R‐miniCHOP versus R‐CHOP in elderly patients with diffuse large B‐cell lymphoma: A propensity matched population‐based study. American Journal of Hematology. 99(2). 216–222. 11 indexed citations

Zhong, Yujie, Joost Kluiver, Sanne H. Tonino, et al.. (2023). A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics. Blood Cancer Journal. 13(1). 130–130. 5 indexed citations

Brink, Mirian, Marjolein van der Poel, Marie José Kersten, et al.. (2022). Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study. Blood. 140(9). 1009–1019. 31 indexed citations

Brink, Mirian, Marjolein van der Poel, Marie José Kersten, et al.. (2022). Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis. European Journal of Cancer. 176. 100–109. 6 indexed citations

Brink, Mirian, Joost S.P. Vermaat, Josée M. Zijlstra, et al.. (2021). Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study. Blood Advances. 5(15). 2958–2964. 16 indexed citations

Brink, Mirian, Pieter Sonneveld, Monique C. Minnema, et al.. (2021). Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study. Blood Cancer Journal. 11(11). 178–178. 7 indexed citations

10.

Heins, M., Judith D. de Jong, Inge Spronk, et al.. (2016). Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics. European Journal of Public Health. 27(4). ckw234–ckw234. 30 indexed citations

11.

Liu, Lifang, Esther de Vries, Marieke W.J. Louwman, et al.. (2010). Prevalence of multiple malignancies in the Netherlands in 2007. International Journal of Cancer. 128(7). 1659–1667. 46 indexed citations

12.

Weijenberg, Matty P., Margreet Lüchtenborg, Anton F.P.M. de Goeij, et al.. (2007). Dietary fat and risk of colon and rectal cancer with aberrant MLH1 expression, APC or KRAS genes. Cancer Causes & Control. 18(8). 865–879. 36 indexed citations

13.

Teunissen, Saskia, et al.. (2006). Telephone consultation in palliative care for cancer patients: 5 years of experience in The Netherlands. Supportive Care in Cancer. 15(6). 577–582. 29 indexed citations

14.

Lüchtenborg, Margreet, Matty P. Weijenberg, Anton F.P.M. de Goeij, et al.. (2005). Meat and Fish Consumption, APCGene Mutations and hMLH1 Expression in Colon and Rectal Cancer: a Prospective Cohort Study (The Netherlands). Cancer Causes & Control. 16(9). 1041–1054. 45 indexed citations

15.

Brink, Mirian, Matty P. Weijenberg, A.F.P.M. de Goeij, et al.. (2005). Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study. British Journal of Cancer. 92(7). 1310–1320. 49 indexed citations

16.

Brink, Mirian, Matty P. Weijenberg, Anton F.P.M. de Goeij, et al.. (2004). Dietary folate intake and k‐ras mutations in sporadic colon and rectal cancer in the Netherlands Cohort Study. International Journal of Cancer. 114(5). 824–830. 22 indexed citations

17.

Brink, Mirian. (2004). Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis. 25(9). 1619–1628. 30 indexed citations

18.

Engeland, Manon van, Matty P. Weijenberg, Guido M.J.M. Roemen, et al.. (2003). Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.. PubMed. 63(12). 3133–7. 234 indexed citations

19.

Brink, Mirian. (2003). K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis. 24(4). 703–710. 256 indexed citations

20.

Engeland, Manon van, Guido M.J.M. Roemen, Mirian Brink, et al.. (2002). K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene. 21(23). 3792–3795. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact